- CARES Act: experts identified safeguards to help selected HHS agencies protect against potential political interference : report to congressional requesters1
- CBO’s analysis of the long-term budgetary outlook: presentation at the University of Michigan’s 71st Annual Economic Outlook Conference1
- CBO’s role and most recent long-term budget projections: presentation at a meeting of the National Conference of State Legislatures' budget working group1
- CDC has improved the nursing home reporting process for COVID-19 Data in NHSN, but challenges remain1
- CDC provided oversight and assistance: however, ELC recipients still faced challenges in implementing COVID-19 screening testing programs1
- CDC’S Vaccines for Children program recipients did not conduct site visits at some providers as required1
- CDC’s internal control weaknesses led to its initial COVID-19 test kit failure, but CDC ultimately created a working test kit1
- CMS can do more to leverage Medicare claims data to identify unreported incidents of potential abuse or neglect1
- COVID-19 Provider Relief Fund: HRSA continues to recover remaining payments due from providers : report to congressional committees1
- COVID-19: USAID plans to share lessons learned from efforts to meet global vaccination goal : report to congressional addressees1
- Changes in the list prices of prescription drugs, 2017-20231
- Cleaner health care: hospital emissions mitigation1
- Community care hubs: a promising model for health and social care coordination1
- Competition in prescription drug markets, 2017-20221
- Complex, time-consuming, and frustrating: searching for in-network diabetes care with marketplace insurance1
- Compliance policy regarding blood and blood component donation suitability, donor eligibility and source plasma quarantine hold requirements: guidance for industry1
- Criminal abortion: its nature, its evidence, and its law1
- Defense health care: DOD assessment needed to ensure TRICARE behavioral health coverage goals are being met : report to congressional committees1
- Development and licensure of vaccines to prevent COVID-19: guidance for industry1
- Development of monoclonal antibody products targeting SARS-CoV-2 for emergency use authorization: guidance for industry1